Breast

Article	Citations
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis	2264
Editorial Board	217
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients	178
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines	156
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients	121
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes	114
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer	105
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling	93
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients	86
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)	75
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study	72
Corrigendum to “Current pattern of care in radiation therapy for DCIS in Australia - where are we heading?” [The Breast 82(2025) 104482]	67
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer	67
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology	64
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?	55
Editorial Board	50
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions	48
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction	45
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study	45
Impact of stereotactic body radiation therapy on systemic therapeutic line change in oligometastatic breast cancer	45
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective	45
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score	42
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target	41
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer	40
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS	39

The continuing conundrum in oligometastatic breast carcinoma: A real-world data	39
Response to comment on: “Global guidelines for breast cancer screening: A systematic review”	38
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?	38
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery	38
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience	37
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY	36
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?	35
No association between breast pain and breast cancer	34
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT	32
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures	32
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)	32
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study	32
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer	32
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers	31
Increasing incidence of breast cancer in young women over time	30
Sarcopenia in patients with metastatic breast cancer: A systematic review and meta-analysis	30
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis	29
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cance	29
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes	28
P026: Prediction of response to anti-HER2 therapy using multigene assay	28
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis	28
P047: Clinicopathologic features and survival outcomes of metaplastic breast carcinoma patients: 20-year outcome results from an academic medical center in the United States	27
P316: Clinical Management and Oncological Outcomes of Pure Pleomorphic and Florid Lobular Carcinoma in Situ of the Breast: Results fromthe MultiLCIS/OPBC International Multicentric Study	27
P335: Indocyanine green angiography for preventing postoperative mastectomy complications in immediate breast reconstruction. Protocol study	27
P280: Identifying Predictive Factors of Lymph Node Involvement in Stage I and II Luminal Breast Cancers to Optimize Neoadjuvant Chemotherapy Indication	27
P390: Extreme Oncoplastic Breast Conservation surgery: Indications and techniques	26
P061: Tumor-infiltrating lymphocytes and tertiary lymphoid structures are associated with a higher upstaging risk of ductal carcinoma in situ in breast biopsies	25
P018: Extended adjuvant (adj) neratinib in HER2+/HR+ early breast cancer (eBC) in clinical routine – interim analysis of the multinational, prospective, non-interventional study (NIS) ELEANOR (n = 300	25
P002: Genomic And Transcriptomic Profiling of Primary Tumors From Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) in the monarchE Trial	25
P028: Confronting Barriers in HER2-Positive Metastatic Breast Cancer: Insights from a Phase II Trial of Inetetamab, Pyrotinib, and Chemotherapy	24
P040: Characterisation of Tropomyosin 3, a novel hypoxia induced gene, in Triple Negative Breast Cancer	24
Preoperative reference values for breast cancer patients using the BREAST-Q	23
P430: Design of a single-institution prospective observational study to evaluate the efficacy and tolerability of four-drug antiemetic therapy for anthracycline-based chemotherapy for early breast can	23
Treatment of oligometastatic breast cancer: The role of patient selection	23
Reply to the letter: What can paintings teach us?	23
P114: Evaluation of Sentinel Lymph Node by Sonography	23
Author Index	23
A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23–05)	22
P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes	22
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study	22
The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer	22
P439: ELEGANT: Elacestrant vs Standard ET in Women and Men With Node-positive, ER+, HER2- Early Breast Cancer (eBC) With High Risk of Recurrence – A Global, Multicenter, Randomized, Openlabel Phase 3	22
P423: Breast cancer survivors and patients’ perspectives on supportive cancer care at the Peace and Love Hospitals in Ghana	22
SA 2.4 Assessing clinical utility and clinical validity of biomarkers in clinical trials	21
P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?	21
P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology	21
P264 The Comparison Outcome of Implant-based Breast Reconstruction with ADM, Non-ADM and TiLOOP Reconstruction in Breast Cancer Patients: A Case Series	20
PO75 A GLOBAL SURVEY OF YOUNG ADULTS LIVING WITH ALL STAGES OF BREAST CANCER WITH PARTICULAR INTEREST IN THOSE WITH METASTATIC BREAST CANCER, THEIR CO-SURVIVORS, AND THE HEALTHCARE PROVIDERS THAT CARE	20
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis	20
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows	20

Therapeutic mammaplasty does not increase false positive findings on surveillance mammography and ultrasound	20
P242 Use of Acellular Pericardial Biological Mesh for Prepectoral and Dual Plane Prosthetic Breast Reconstruction Following Conservative Mastectomies	20
P005 Impact of oral bacterial counts on febrile neutropenia during breast cancer chemotherapy	19
Author Index	19
PR137 CLINICALLY NODE NEGATIVE T4B BREAST CANCER IS A POOR INDICATION OF AXILLARY CLEARANCE: A SINGLE CENTRE EXPERIENCE	19
PO148 A RANDOMIZED, CONTROLLED, PARALLEL-GROUP, TRIALON THE LONG-TERM EFFECTS OF MELATONIN ON FATIGUE ASSOCIATED WITH BREAST CANCER AND ITS ADJUVANT TREATMENTS	19
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, ran	18
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases	18
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis	18
Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer	18
Essential amino acids deprivation is a potential strategy for breast cancer treatment	18
Switching to T-DM1 remains justified in patients with HER2-negative residual invasive breast cancer after neoadjuvant therapy	18
Are English-language online patient education materials related to breast cancer risk assessment understandable, readable, and actionable?	18
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outco	18
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial	18
P029: The contribution of the double blockade “Pertuzumab – Trastuzumab” in neo-adjuvant situation in localized Her2 positive Breast Cancers (Algerian experience)	17
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased r	17
P432: Exploring the Role of Precision Medicine in Adjuvant Systemic Therapy for Early-stage Breast Cancer: A Prospective Cohort Study	17
Psychoeducation for breast cancer: A systematic review and meta-analysis	17
P441: Breaking Barriers: Addressing Delayed Breast Cancer Diagnosis in Rural India through Cultural Sensitivity and Gender-Specific Care	17
P041: Distinguishing Second Ipsilateral Locoregional Breast Cancer as True Recurrence or New Primary: A Comparison of Clinicopathological Classification and Molecular Clonality Analysis	16
P075: The Benefits of comprehensive NGS Panels using Liquid Biopsy in Breast Cancer	16
P160: The effectiveness of trastuzumab emtansine (TDM1) in metastatic breast cancer based on the duration of response to adjuvant HER2-targeted therapy	16
P111: Cost-effectiveness of a breast cancer screening program in Switzerland	16
P427: Exploring Treatment Adherence and Unmet Needs of Older Breast Cancer Patients in Nigeria	15
P242: Global disparities in breast cancer treatment – an international survey	15
P186: Post-mastectomy radiotherapy negatively impacts short-term patient-reported outcomes in patients with and without immediate reconstruction – a retrospective cohort study	15
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest in breast surgical oncology	15
P336: Sentinel Lymph Node Biopsy: Retrospective Analysis of Prognostic and Predictive Factors to Assess the Omission of Axillary Surgery	15
P284: Navigating Physical and Emotional Challenges After Mastectomy Without Reconstructive Surgery: A Study in Rural India	15
Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomy	15
P343: Surgical management of positive margins after breast conservative surgery: 5-years monoistitutional records with 5-years follow-up	15
P181: Acute and Late Toxicity after Hypofractionated Radiotherapy in Breast Cancer Patients Received Neoadjuvant Chemotherapy-Experience of our Department	15
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?	14
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database	14
P187 Comparison of long term oncologic outcome of sentinel lymph node mapping methods, dye-only versus dye and radioisotope in breast cancer following neoadjuvant chemotherapy	14
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program	14
Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health	14
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany	14
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ	14
SA 2.3 Multi-omic machine learning prediction of treatment response	14
Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer	14
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer	14
P168 OncotypeDX RS new TAILORx cut-offs: omitting Chemotherapy in more patients aged >50 years with Early Breast Cancer	14
BP52 DEVELOPMENT OF AN INFORMATION FILM FOR FRIENDS AND FAMILY OF PATIENTS WITH MBC “THEY JUST DON’T KNOW WHAT TO SAY OR DO”	14
P293 Classification of abnormal findings on dedicated breast PET for prediction of malignancy	13
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?	13
P281 The effect of Chinese culture on family planning of Childbearing age women with breast cancer in North China	13
P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy	13
P105 Internal mammary chain irradiation in breast cancer patients: Which patterns of practice between controversial benefit and challenging dosimetry?	13
PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXIC	13
P095 Ultra-hypofractionated adjuvant radiotherapy in very elderly ratients with early breast cancer	13
P161 The updated PREDICT breast cancer prognostication in 91, 182 patients using Korean Breast Cancer Registry Data	13
P189 Impact assessment of sentinel lymph node core needle biopsy guided by ultrasound for node-positive breast cancer patients	13
Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline	13
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study	13
P065 High satisfaction of women in Slovenian breast cancer screening program DORA: results of an anonymous survey	13
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival	12
P134: Eligibility for bilateral prophylactic mastectomy: an expert opinion study in the Netherlands	12
P226: Real world evidence of neoadjuvant chemotherapy without anthracyclines in triple-negative breast cancer among Mexican patients	12
P240: Mapping cancer care trajectories: Treatment and service lived experiences of women with breast cancer	12
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study	12
On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19	12
Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis	12
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer	12
P306: Comparison of oncological outcomes of Breast Reconstruction, Breast-Conserving, and Mastectomy Surgery in Breast Cancer Patients Undergoing Neoadjuvant Treatment: A Propensity Scorematched Analy	12
P356: New Method for Nipple-Areolar Complex Reconstruction with FixNip - Nipple Reconstruction Implant (FixNip NRI™): A Preliminary Study	12
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants	12
Skin perfusion and oxygen saturation after mastectomy and radiation therapy in breast cancer patients	12
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data	12
The impact of breast density notification on psychosocial outcomes in racial and ethnic minorities: A systematic review	12
P032: Brown adipocytes are more capable than ASC in promoting breast cancer invasiveness through cell fusion	12
P346: Pre-operative MRI vs. no MRI in patients with ductal carcinoma in situ treated at two oncology centers in Lima, Peru (2016–2023): A real-world data analysis	12
P374: Comparison of Radioguided Occult Lesion Localization (ROLL) and Magnetic Marker Techniques for Preoperative Localization of Non-Palpable Breast Lesions in Breast-Conserving Surgery	12
Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period	12
Chemotherapy in older patients with early breast cancer	12
P299: A Systematic Cavity-Saving Technique for Reducing Margin Positivity in Breast-Conserving Surgery: A Cost-Effective Alternative to Frozen Section Biopsy (CSRP Study)	12
Multimodal data integration in early-stage breast cancer	11
P208 Contrast-enhanced ultrasound using intradermal microbubble sulfur hexafluoride for identification of sentinel lymph nodes during breast cancer surgery: a clinical trial	11
P265 Cryoablation in Breast Cancer Care - an analysis from a Single Multi-Disciplinary Unit in Southern Africa	11

“Alas … my sickness becomes my family's burden”: A nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia	11
Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes	11
The role of vacuum assisted excision in diagnosis of papillary lesions without atypia	11
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention	11
IN24 AI SUPPORTING PATIENT-CENTRIC HEALTHCARE LEARNING	11
P016 Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland	11
Knowledge in Motion: A Decade Reviewed, A Future Defined – The ABC Global Alliance 2015-2025 Decade Report and 2025-2035 Global Charter	10
IN25 WHEN SHOULD THE PRIMARY TUMOR BE TREATED IN ABC?	10
P133 Immunohistochemical expression of estrogen receptors after neoadjuvant chemotherapy in breast cancer	10
P003 ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression	10
P085 Target axillary disecction in cN2 breast cancer patients after neoadjuvant chemotherapy. Preliminary results	10
Poster Session	10
BP48 WHAT IS A LIFE WITH MBC WORTH? THE CANCER CURRENCY CAMPAIGN: DEMANDING EQUITABLE TREATMENT FOR THOSE LIVING WITH METASTATIC BREAST CANCER	10
Breast and axillary surgery after neoadjuvant systemic treatment – A review of clinical routine recommendations and the latest clinical research	10
Does mammographic density predict survival in women with invasive breast cancer? The need to account for potential confounding from cancer stage and overdiagnosis	10
SA 5.2 Risk assessment in ER positive disease: Who should receive CDK 4–6 inhibitors?	10
PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERING METASTATIC DISEASE CLINICAL ISSUES: SUPPORTIVE AND PALLIATIVE CARE	10
P215 Absent post-treatment changes in negative sentinel lymph nodes and regional recurrence in initially node positive breast cancer patients	9
PO65 PSYCHOLOGICAL AND RELIGIOUS COPING STRATEGIES IN MOROCCAN WOMEN RECENTLY DIAGNOSED WITH LOCALLY ADVANCED BREAST CANCER: BASELINE FINDINGS FROM COHORT STUDY	9
P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?	9
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data	9
P451: Participation of a breast cancer patient in the multidisciplinary team - from decision making to changing the treatment option	9
PR125 EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER	9
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life	9
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer	9
P208: Use of MammaTyperin predicting response to neoadjuvant therapy in HER2-positive breast cancer	9
P074: Epithelial-Mesenchymal Transition Markers Expression in Male Breast Cancer	9
P211 Surgical treatment for elderly patients with ductal carcinoma in situ. Is it still a safety and valid option?	9
P283 Overall survival of patients treated for breast cancer: about 124 cases	9
PO91 A LIQUID BIOMARKER REFLECTING PROLIFERATION RATE - THYMIDINE KINASE ACTIVITY - PROVIDES UNIQUE GUIDANCE FOR PREDICTING THERAPY EFFICACY AND MONITORING OF ADVANCED BREAST CANCER	9
P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer	9
Corrigendum to ‘Raising awareness of alcohol as a modifiable risk factor for breast cancer: A randomized controlled trial comparing the efficacy of accessing an interactive website with a non-interact	9
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC	9
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy	9
P089: MammaTyper test as a predictive biomarker of neoadjuvant chemo-immunotherapy response in patients with estrogen receptor (ER) low HER2 negative breast cancer	9
P476: Evaluation of Short-Term Postoperative Pain in Breast Surgery Patients using Regional Technique as an Adjuvant	9
BP132 LOCAL HERO: A PHASE II STUDY OF LOCAL THERAPY ONLY (STEREOTACTIC RADIOSURGERY AND/OR SURGERY) FOR TREATMENT OF UP TO 5 BRAIN METASTASES FROM HER2+ BREAST CANCER. (TROG STUDY 16.02)	9
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study	9
P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers	9
The Design And Development Of an Individualised Training Program For Metastatic Breast Cancer (MBC) Nursing Incorporating Remote And Onsite Learning Experiences During A Pandemic	9
Is preoperative imaging of sentinel lymph node in breast cancer necessary? A retrospective case control study	9
P415: Sleep quality and influencing factors among tunisian breast cancer patients	9
P370: The Alexisretractor in axillary surgery for breast cancer: a preliminary study on reducing surgical complications and enhancing surgical efficiency	9
P012: 5-year vs 10-year Hormone Therapy: Comparison of Recurrence in Patients with Luminal A and Luminal B Breast Cancer	9
Contralateral Breast Cancer: Influence Of Molecular Subtype, Clinical Features And Treatment Given In A Single Institution Study	8
Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy	8
The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review	8
P281: India’s exploration of next-generation sequencing: proteomics based prognostic signature redefining the risk groups in HR +/HER2-negative breast cancer and comparative analysis with grade, Ki67	8
P320: Malignant phyllodes tumor of the breast- experience from a tertiary care center	8
P380: Rates of Skin and Nipple Necrosis with Inframammary Fold Approach in Nipple-Sparing Mastectomy: A 5-Year Retrospective Single-Center Study	8
Climate change impacts and sustainability integration among breast international group members	8
Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?	8
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review	8
Locally advanced breast cancer	8
P368: De-escalation of axilla based on ultrasound, is the clinic ready?	8
P250: Investigation of Circulating miR-182-3p, miR-382-3p and miR-93, miR -142-3p Involved in Tamoxifen Resistance and Sensitivity in Luminal-Subtype Breast Cancer Patients: A Case-Control Study	8
Improving medication adherence to endocrine therapy in breast cancer patients: a mixed-methods systematic review of effective communication strategies for healthcare providers	8
The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients	8
The features of male breast cancer in China: A real-world study	8
Reproductive risk factors associated with breast cancer in young women by molecular subtype	8
Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025−2035 (Goal 3)	8
Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives	8
Survival of patients with squamous cell carcinoma of the breast compared with invasive ductal carcinoma by biological subtype: A matched analysis of the Japanese national clinical database-breast canc	8
P353: Lymphedema after mastectomy and immediate breast reconstruction – a comparison between patients with and without breast reconstruction in a prospective study	8
P156: The Relevance of Rising Breast Cancer Incidence Among Young Women Under 45 in Ukraine: Challenges in Oncofertility	8
P098: Role of Contrast-Enhanced Mammography in Breast Cancer: Current Status and Future Directions	8
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer	8
PO84 LESSONS LEARNED IN DEVELOPING A TREATMENT ACCESS PROGRAM FOR ADVANCED BREAST CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES	8
P230 Breast reconstruction: recurrence in patients with mastectomy and immediate breast reconstruction	7
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial	7
P033: Targeting Cell Death in MCF-7 Breast Cancer Cells with Green Synthesized Silver Nanoparticles	7
P057: TLD-1, a Second-Generation Nano-Liposomal Doxorubicin, in Patients with Advanced Breast Cancer from the Dose Escalation and Expansion Phase 1 Study (SAKK 65/16)	7
P178: Ultra-hypofractionated Breast Radiotherapy in patients receiving Systemic Treatment: A risky combination?	7
IN1 THE SPARK THAT LIT THE FIRE - LILLIE’S JOURNEYS WITH ABC PATIENTS AND THEIR FAMILIES	7
PO69 CAPTURING LIFE IN COLOR: DOCUMENTING THE LIVED EXPERIENCES OF ADVANCED BREAST CANCER PATIENTS	7
PO82 PERSPECTIVES OF FEMALE HIGH SCHOOL STUDENTS IN GHANA, NAMIBIA, MALAWI AND ZAMBIA: HOW LACK OF ACCESS TO HOLISTIC CANCER CARE FUELS ADVANCED BREAST CANCER IN AFRICA	7
P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer.	7
P413: Unlocking the potential of metastasis-directed surgery in multidisciplinary management of OLiGometAstatic breast cancer patients: The OLGA Study	7
P188: Brachytherapy Indices- A lesser explored parameter to evaluate cosmesis in patients post Breast Conservation Therapy	7
P138: Impact of Awareness Campaigns on Breast Cancer Diagnosis: A Retrospective Study	7
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective	7
SA 10.3 Breast cancer treatment and research from an African perspective	7
P155 Exploration of specific population for adjuvant capecitabine escalation therapy in early-stage triple-negative breast cancer: a retrospective biological sample analysis of the CBCSG010 clinical t	7
Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy	7
P167 Prediction of Axillary lymph node metastasis by Tumor to breast ratio in breast cancer	7
P049 Investigating the pathogenesis of poor-outcome Triple-Negative Breast Cancer	7
P037: Androgen Receptor Expression and Clinicopathological Features in Triple Negative Breast Cancer	7
P136: Mamamia: a Pilot Program to accelerate Breast Cancer Diagnosis in Patients with suspicious Findings on Breast Image Studies in Nuevo Leon, Mexico	7
P418: Administration of GnRH agonists during neoadjuvant therapy - single institution experience	7
The early Monash experience with targeted axillary dissection: lessons, pitfalls and practice patterns	7
P238 Is BCT safer than Mastectomy for the treatment of early breast cancer?	7
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer	7
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial	6
PR123 REAL-WORLD DATA: IMPACT OF LOW HER-2 EXPRESSION IN METASTATIC HR+/HER2- BREAST CANCER TREATED WITH PALBOCICLIB	6
P221 Using an ultra-low dose of superparamagnetic iron oxide for sentinel lymph node detection in breast cancer patients - the MAGSNOW feasibility study	6